By 2008, Pfizer’s DTP patent was long expired, and there were sixty-three manufacturers making the vaccine in forty-two countries with large surpluses and very low margins. The Gates cabal solved these profiteering problems by brewing up a new (five diseases) vaccine by mixing the DTP, Hib, and hepatitis B formulas in a single syringe. That new combination became a “new vaccine.”

